Source à consulter
OpenAI has announced the acquisition of startup Orchestra Bio to bolster its biotech business. This acquisition will enable OpenAI to integrate Orchestra's team and technology into its Rosalind AI model for life sciences research and its Rosalind Workbench tool.
Rosalind is an AI model designed for life sciences research, while Rosalind Workbench is a tool that helps researchers plan and analyze their experiments. The integration of Orchestra's team and technology is expected to enhance these capabilities and enable OpenAI to better serve the needs of life sciences researchers.
This acquisition is expected to have a positive impact on the life sciences research community, which will now have access to a more powerful and efficient platform for planning and analyzing experiments. Creators and designers will also benefit from this evolution to develop new tools and applications that meet the needs of life sciences researchers.
Titre et date issus du flux; image déclarée par la page source, réponse image vérifiée. Synthèse à relire.
← Continuer à explorer